Affinity Beyond News Today

Regenxbio Inc. announced that the FDA has granted fast track designation for RGX-202, a one-time gene therapy for treatment of Duchenne muscular dystrophy.According to a release from the company, the FDA previously granted orphan drug designation and rare pediatric disease designation for RGX-202, which is designed to support delivery and expression of genes in heart and skeletal muscle using the

The Group 2 Villiers Stakes trophy stayed with Mark Newnham after the local conditioner combined with Rachel King for successive wins in the summer feature mile. Greysful Glamour was too quick for them in controlling the race from start to finish to hold out the Godolphin duo Best Of Days and Criaderas and give Newnham and King another win after being successful with Quackerjack in 2019. The good track was played very fast with Happy Clapper’s record in the Group 2 Villiers eclipsed while t...